FDA inspection
AstraZeneca Pharmaceuticals, LP: FDA inspection ending Nov 3, 2005
FDA inspection 401674 · No Action Indicated (NAI) · Newark, DE
Key facts
| Inspection ID | 401674 |
|---|---|
| Firm | AstraZeneca Pharmaceuticals, LP |
| FEI number | 2517100 |
| Address | 587 Old Baltimore Pike |
| City | Newark |
| State | DE |
| ZIP | 19702-1307 |
| Fiscal year | 2006 |
| Inspection end date | Nov 3, 2005 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data